trial · primary record
Cyclophosphamide
Lymphodepleting Chemotherapy
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 44 |
| Primary completion | 2029-04-01 |
| Primary endpoint | Safety and adverse events (AEs) |
| Registry ID | NCT06383572 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:22.416Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06383572
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.